Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Levels of Salivary Paxillin Oral Premalignant and Malignant Lesions

NCT06154551 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT06154551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06154551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Levels of Salivary Paxillin Oral Premalignant and Malignant Lesions
Lead sponsor
Cairo University
Phase
Observational
Overall status
Completed
Start date
November 29, 2022
Completion date
November 1, 2023
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

comparison of salivary paxillin levels in opmls and oscc to healthy subjects